ALERT: These are the signs that it\’s cre…See more

A 55-year-old woman developed painful, red facial and neck lesions with fever two days after starting inhaled indacaterol/glycopyrronium for COPD. Blood tests showed neutrophilia; biopsy confirmed Sweet syndrome.

Lesions improved with corticosteroids after stopping the drug. This is the first reported case linked to inhaled therapy, highlighting the need for primary care awareness of rare drug reactions and the importance of ruling out systemic disease.

Related Posts

Why A Simple Cup of Salt Could Save Your Car And Your Health

If you’ve ever gotten into your car and been greeted by foggy windows and a musty odor, you’re not alone. These common issues, especially in older vehicles,…

House Approves ‘Take It Down’ Act to Combat Deepfake Revenge Imagery

The House has overwhelmingly passed the Take It Down Act, a bill aimed at combating deepfake porn—nonconsensual AI-generated sexual content—with a vote of 409–2. The law makes…

He Had No Home, No Family—except for the Cat That Slept on His Chest Every Night. “she Chose Me,” He Said. “that’s All That Matters.”

The first time I saw him, he was outside the 24-hour laundromat, curled on a ripped camping mat. A small orange cat with half an ear lay…

Much pain and sadness, the dear pi died in a very serious accident!

On Saturday afternoon, the 7th, a tragic accident on the SC-390 highway in Ipira, Santa Catarina, claimed the life of a 31-year-old motorcyclist. The violent head-on collision…

Travis Kelce shares heartbreaking news about Taylor Swift: My heart is broken

Travis Kelce, the NFL star tight end celebrated for his game-changing plays and lively personality, has revealed a deeply personal chapter involving global pop icon Taylor Swift….

Rare Creature Caught On Camera For The 1st Time, Leave Scientists Stunned!

Canadian scientists have captured the first-ever video of an extremely rare melanistic Canada lynx, stunning wildlife experts and sparking worldwide fascination. Unlike the species’ usual gray or…

Leave a Reply

Your email address will not be published. Required fields are marked *